| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |